ImmunityBio (IBRX) Interest Coverage Ratio (2014 - 2026)
ImmunityBio's (IBRX) quarterly Interest Coverage Ratio came in at 0.91 in Q1 2026, up 78.08% year-on-year from 0.51 in Q1 2025, and up 79.22% on a QoQ basis from 4.36 in Q4 2025.
ImmunityBio (IBRX) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of Interest Coverage Ratio data on file, last reported at 0.91 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 78.08% year-over-year to 0.91 in Q1 2026; TTM through Mar 2026 was 3.39, a 8.99% decrease from a year earlier, with the FY2025 full-year figure at 0.3, up 32.46% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.91, up from 4.36 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for IBRX reached as high as 4.55 in Q4 2022 and fell as low as 213.47 in Q4 2023.
- Historically, Interest Coverage Ratio has averaged 16.01 across 5 years, with a median of 3.65 in 2025.
- Across the five-year window, Interest Coverage Ratio jumped 103.67% in 2022 and sank 4790.11% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 4.55 in 2022, then sank by 4790.11% to 213.47 in 2023, then jumped by 98.75% to 2.67 in 2024, then sank by 63.39% to 4.36 in 2025, then jumped by 79.22% to 0.91 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.91 in Q1 2026, 4.36 in Q4 2025, and 3.65 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | -0.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.91 |
| Dec 31, 2025 | -4.36 |
| Sep 30, 2025 | -3.65 |
| Jun 30, 2025 | -4.61 |
| Mar 31, 2025 | -4.13 |
| Dec 31, 2024 | -2.67 |
| Sep 30, 2024 | -2.74 |
| Jun 30, 2024 | -3.33 |
| Mar 31, 2024 | -3.23 |
| Dec 31, 2023 | -213.47 |
| Sep 30, 2023 | -2.29 |
| Jun 30, 2023 | -2.64 |
| Mar 31, 2023 | -3.74 |
| Dec 31, 2022 | 4.55 |
| Sep 30, 2022 | -5.42 |
| Jun 30, 2022 | -8.21 |
| Mar 31, 2022 | -11.30 |
| Dec 31, 2021 | -123.87 |
| Sep 30, 2021 | -21.81 |
| Jun 30, 2021 | -1.95 |